» Articles » PMID: 14268414

IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS

Overview
Specialty Pharmacology
Date 1965 Feb 1
PMID 14268414
Citations 104
Authors
Affiliations
Soon will be listed here.
Citing Articles

Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson's disease.

Rahman M, Chakraborti R, Potol M, Abir A, Sharmin O, Alam M Animal Model Exp Med. 2020; 3(1):9-21.

PMID: 32318655 PMC: 7167235. DOI: 10.1002/ame2.12097.


Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach.

Johnson M, Kozielska M, Pilla Reddy V, Vermeulen A, Barton H, Grimwood S Pharm Res. 2014; 31(10):2605-17.

PMID: 24792824 DOI: 10.1007/s11095-014-1358-7.


Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.

Zhang C, Fang Y, Li M Pharmacol Biochem Behav. 2011; 98(1):155-60.

PMID: 21194545 PMC: 3040423. DOI: 10.1016/j.pbb.2010.12.018.


Dopamine D2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive {alpha}4 nicotinic receptors via a cholinergic-dependent mechanism.

Zhao-Shea R, Cohen B, Just H, McClure-Begley T, Whiteaker P, Grady S FASEB J. 2009; 24(1):49-57.

PMID: 19720621 PMC: 2797035. DOI: 10.1096/fj.09-137034.


Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.

Li M, He W, Mead A Behav Pharmacol. 2009; 20(1):84-98.

PMID: 19179852 PMC: 5248571. DOI: 10.1097/FBP.0b013e3283243008.